

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.53197962 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.47826645 |
| 3 | exogenous drug catabolic process (GO:0042738) | 8.38162528 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.82048111 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.82048111 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.46796444 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.46796444 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.99543274 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.27395246 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.27395246 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.27395246 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25756402 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.13656081 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.98128886 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.89816263 |
| 16 | urea metabolic process (GO:0019627) | 5.86225463 |
| 17 | urea cycle (GO:0000050) | 5.86225463 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.76217828 |
| 19 | oxidative demethylation (GO:0070989) | 5.68673498 |
| 20 | drug metabolic process (GO:0017144) | 5.68673395 |
| 21 | cysteine metabolic process (GO:0006534) | 5.62308324 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.58684912 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52496714 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.50290509 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46325457 |
| 26 | ethanol metabolic process (GO:0006067) | 5.41280392 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.39560395 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.38502321 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37452931 |
| 30 | protein carboxylation (GO:0018214) | 5.37452931 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.35598373 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.33039541 |
| 33 | regulation of protein activation cascade (GO:2000257) | 5.31002546 |
| 34 | bile acid metabolic process (GO:0008206) | 5.11907449 |
| 35 | homocysteine metabolic process (GO:0050667) | 5.10137756 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.09538050 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 4.99197699 |
| 38 | regulation of complement activation (GO:0030449) | 4.96025951 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.90996516 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.81965359 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.80046756 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.78119069 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.73570794 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72410176 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71275414 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.71275414 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.71275414 |
| 48 | lysine metabolic process (GO:0006553) | 4.67959813 |
| 49 | lysine catabolic process (GO:0006554) | 4.67959813 |
| 50 | glycine metabolic process (GO:0006544) | 4.66006120 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.61384105 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.59044910 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.59044910 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.56558143 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.56558143 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.55682580 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.55267587 |
| 58 | phospholipid efflux (GO:0033700) | 4.45883246 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.44351584 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.43854523 |
| 61 | regulation of plasminogen activation (GO:0010755) | 4.43008905 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.42237701 |
| 63 | glutamate metabolic process (GO:0006536) | 4.41888117 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.40088525 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.39102382 |
| 66 | amine catabolic process (GO:0009310) | 4.35488641 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.35488641 |
| 68 | S-adenosylmethionine metabolic process (GO:0046500) | 4.32758635 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.30288009 |
| 70 | serine family amino acid biosynthetic process (GO:0009070) | 4.27424202 |
| 71 | cellular glucuronidation (GO:0052695) | 4.24455995 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.23297803 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.15930213 |
| 74 | cholesterol efflux (GO:0033344) | 4.15771026 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.14955690 |
| 76 | arginine metabolic process (GO:0006525) | 4.13557719 |
| 77 | ethanol oxidation (GO:0006069) | 4.08968279 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.99277057 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.99198948 |
| 80 | fibrinolysis (GO:0042730) | 3.95067523 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.91616594 |
| 82 | drug catabolic process (GO:0042737) | 3.91180927 |
| 83 | cofactor catabolic process (GO:0051187) | 3.86640198 |
| 84 | negative regulation of blood coagulation (GO:0030195) | 3.84138363 |
| 85 | negative regulation of hemostasis (GO:1900047) | 3.84138363 |
| 86 | opsonization (GO:0008228) | 3.82624887 |
| 87 | organic acid catabolic process (GO:0016054) | 3.82069670 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.82069670 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81697799 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81273868 |
| 91 | alkaloid metabolic process (GO:0009820) | 3.79983327 |
| 92 | ketone body metabolic process (GO:1902224) | 3.79791270 |
| 93 | regulation of humoral immune response (GO:0002920) | 3.79001263 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.75830671 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.75159313 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.75159313 |
| 97 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72383158 |
| 98 | complement activation (GO:0006956) | 3.71110468 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.71071551 |
| 100 | acetyl-CoA metabolic process (GO:0006084) | 3.70853015 |
| 101 | acute-phase response (GO:0006953) | 3.68855331 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68401388 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68401388 |
| 104 | negative regulation of lipase activity (GO:0060192) | 3.68216679 |
| 105 | protein activation cascade (GO:0072376) | 3.68030395 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 3.68013586 |
| 107 | short-chain fatty acid metabolic process (GO:0046459) | 3.67602577 |
| 108 | cytolysis (GO:0019835) | 3.67452839 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 3.66469171 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.65946329 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.65089952 |
| 112 | sterol homeostasis (GO:0055092) | 3.64913933 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.63111740 |
| 114 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.61946663 |
| 115 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.61946663 |
| 116 | NAD biosynthetic process (GO:0009435) | 3.59727176 |
| 117 | aspartate family amino acid catabolic process (GO:0009068) | 3.59706887 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.55268350 |
| 119 | negative regulation of wound healing (GO:0061045) | 3.48224487 |
| 120 | negative regulation of coagulation (GO:0050819) | 3.43058109 |
| 121 | flavonoid metabolic process (GO:0009812) | 3.35020050 |
| 122 | heme transport (GO:0015886) | 3.32230433 |
| 123 | steroid catabolic process (GO:0006706) | 3.31275498 |
| 124 | proline metabolic process (GO:0006560) | 3.30300987 |
| 125 | positive regulation of blood coagulation (GO:0030194) | 3.27330156 |
| 126 | positive regulation of hemostasis (GO:1900048) | 3.27330156 |
| 127 | oxaloacetate metabolic process (GO:0006107) | 3.25455555 |
| 128 | L-serine metabolic process (GO:0006563) | 3.25267378 |
| 129 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.20959791 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.16759637 |
| 131 | positive regulation of coagulation (GO:0050820) | 3.06479260 |
| 132 | synaptic vesicle maturation (GO:0016188) | 3.05560233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.44643343 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.24761677 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.03205187 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51283066 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.43636590 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17967986 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71723151 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06617009 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05263117 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.23951658 |
| 11 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12681239 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11440128 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08831642 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.1115525 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99450537 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98176967 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95090834 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83758249 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76576069 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62255599 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60278934 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57758561 |
| 23 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55482566 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.48817350 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47229471 |
| 26 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42298040 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41285928 |
| 28 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.38616306 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31225096 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30869583 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30398603 |
| 32 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.29333973 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28922244 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25399546 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22149331 |
| 36 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20399936 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.18553257 |
| 38 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13308877 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12251565 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08712751 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04227134 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00280994 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99775613 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94919983 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94376443 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94376443 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92638007 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91976270 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.90816915 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90191972 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90084849 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89881611 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89196206 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89194139 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87991577 |
| 56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87545434 |
| 57 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84440696 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84298602 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.83800581 |
| 60 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83366815 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.82737425 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81456054 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80238517 |
| 64 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80191883 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79517933 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79352836 |
| 67 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78574379 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.78405124 |
| 69 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78326261 |
| 70 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.77876178 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77736182 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77036364 |
| 73 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.76923584 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76746866 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76677986 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.75873305 |
| 77 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.75506442 |
| 78 | AR_19668381_ChIP-Seq_PC3_Human | 0.75081458 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.74617776 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.74570494 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74447971 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73923101 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73505312 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.71745754 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.71117043 |
| 86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.71034348 |
| 87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.70671769 |
| 88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.70568690 |
| 89 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.70494436 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70451021 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69893971 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 0.69885943 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69705639 |
| 94 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.68633369 |
| 95 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66249549 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66220553 |
| 97 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.65660902 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65548900 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65430987 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 0.65287910 |
| 101 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.65204581 |
| 102 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.63904312 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63863467 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63528307 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.62445684 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.62285111 |
| 107 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62248857 |
| 108 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.61896198 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.61675876 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61280633 |
| 111 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60494172 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60426846 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.59575878 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.59545172 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59191601 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58842220 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58842220 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56780140 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55582823 |
| 120 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.55380523 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54372609 |
| 122 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53190405 |
| 123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52419039 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51965364 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51864485 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51431087 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51352050 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49929024 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49828652 |
| 130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.49605757 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49278506 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48979017 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48332615 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46368942 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45298786 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44255178 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43477679 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43174600 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42922161 |
| 140 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40215218 |
| 141 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39812384 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39063603 |
| 143 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38903951 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38724655 |
| 145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.38395449 |
| 146 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.38078518 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37300145 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37271277 |
| 149 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.37146722 |
| 150 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36970329 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.36929545 |
| 152 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.36234070 |
| 153 | GATA1_19941826_ChIP-Seq_K562_Human | 0.36215960 |
| 154 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35920392 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.35756833 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35731511 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35357553 |
| 158 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35117176 |
| 159 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34251037 |
| 160 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34220333 |
| 161 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.33853204 |
| 162 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33635600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.26389508 |
| 2 | MP0005360_urolithiasis | 7.59699988 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.55753641 |
| 4 | MP0005365_abnormal_bile_salt | 6.33039242 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11306794 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.34442193 |
| 7 | MP0003252_abnormal_bile_duct | 3.87312342 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58044978 |
| 9 | MP0005083_abnormal_biliary_tract | 3.29017274 |
| 10 | MP0009840_abnormal_foam_cell | 3.24197915 |
| 11 | MP0003195_calcinosis | 2.88068773 |
| 12 | MP0005332_abnormal_amino_acid | 2.83710924 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.80279155 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.59046097 |
| 15 | MP0003880_abnormal_central_pattern | 2.31524525 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.19939402 |
| 17 | MP0000609_abnormal_liver_physiology | 2.14034984 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.11938440 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.11508853 |
| 20 | MP0003868_abnormal_feces_composition | 2.06289712 |
| 21 | MP0004270_analgesia | 1.96795097 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.91335863 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.82054739 |
| 24 | MP0009745_abnormal_behavioral_response | 1.79993907 |
| 25 | MP0002064_seizures | 1.78463615 |
| 26 | MP0003879_abnormal_hair_cell | 1.74735358 |
| 27 | MP0001764_abnormal_homeostasis | 1.74413367 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.70023962 |
| 29 | MP0009697_abnormal_copulation | 1.56704322 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56033539 |
| 31 | MP0009046_muscle_twitch | 1.48799154 |
| 32 | MP0005451_abnormal_body_composition | 1.47261664 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.45544432 |
| 34 | MP0002272_abnormal_nervous_system | 1.40608408 |
| 35 | MP0003011_delayed_dark_adaptation | 1.28726123 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.27272050 |
| 37 | MP0003186_abnormal_redox_activity | 1.26157563 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.25097172 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.23136901 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.20245225 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.18815780 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.18755022 |
| 43 | MP0000598_abnormal_liver_morphology | 1.17209414 |
| 44 | MP0002736_abnormal_nociception_after | 1.15343430 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.15300189 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.14722162 |
| 47 | MP0003123_paternal_imprinting | 1.14337297 |
| 48 | MP0005647_abnormal_sex_gland | 1.12640004 |
| 49 | MP0002734_abnormal_mechanical_nocicepti | 1.10680748 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.08577404 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.07089726 |
| 52 | MP0000604_amyloidosis | 1.06534422 |
| 53 | MP0001486_abnormal_startle_reflex | 1.05328929 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.02995597 |
| 55 | MP0001984_abnormal_olfaction | 0.99917194 |
| 56 | MP0009763_increased_sensitivity_to | 0.98340868 |
| 57 | MP0009764_decreased_sensitivity_to | 0.97451049 |
| 58 | MP0002254_reproductive_system_inflammat | 0.97274491 |
| 59 | MP0003787_abnormal_imprinting | 0.97274231 |
| 60 | MP0001440_abnormal_grooming_behavior | 0.95549812 |
| 61 | MP0003633_abnormal_nervous_system | 0.90803564 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.88075250 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.86988929 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.86713560 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.85938243 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.85598769 |
| 67 | MP0008469_abnormal_protein_level | 0.83575971 |
| 68 | MP0005408_hypopigmentation | 0.83033246 |
| 69 | MP0005187_abnormal_penis_morphology | 0.82601793 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.81853239 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.81323409 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.80959716 |
| 73 | MP0005386_behavior/neurological_phenoty | 0.80264936 |
| 74 | MP0004924_abnormal_behavior | 0.80264936 |
| 75 | MP0001502_abnormal_circadian_rhythm | 0.80205676 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.80152258 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.77981787 |
| 78 | MP0005670_abnormal_white_adipose | 0.77596327 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.77310828 |
| 80 | MP0000566_synostosis | 0.77087297 |
| 81 | MP0003631_nervous_system_phenotype | 0.74910081 |
| 82 | MP0003122_maternal_imprinting | 0.74519458 |
| 83 | MP0002557_abnormal_social/conspecific_i | 0.74326053 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.73403388 |
| 85 | MP0002971_abnormal_brown_adipose | 0.70214524 |
| 86 | MP0005535_abnormal_body_temperature | 0.70041206 |
| 87 | MP0003329_amyloid_beta_deposits | 0.69068078 |
| 88 | MP0001661_extended_life_span | 0.68298211 |
| 89 | MP0005334_abnormal_fat_pad | 0.68283903 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.68237106 |
| 91 | MP0005266_abnormal_metabolism | 0.68201622 |
| 92 | MP0003690_abnormal_glial_cell | 0.67900129 |
| 93 | MP0004130_abnormal_muscle_cell | 0.66086764 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.65279256 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 0.63611043 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.62942525 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.62819580 |
| 98 | MP0008569_lethality_at_weaning | 0.62269980 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.61508460 |
| 100 | MP0009053_abnormal_anal_canal | 0.61433858 |
| 101 | MP0005448_abnormal_energy_balance | 0.60932589 |
| 102 | MP0002822_catalepsy | 0.60210951 |
| 103 | MP0002067_abnormal_sensory_capabilities | 0.60159925 |
| 104 | MP0004811_abnormal_neuron_physiology | 0.59199121 |
| 105 | MP0001970_abnormal_pain_threshold | 0.58599554 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.57715194 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.57123952 |
| 108 | MP0001756_abnormal_urination | 0.56677801 |
| 109 | MP0010234_abnormal_vibrissa_follicle | 0.54877022 |
| 110 | MP0000920_abnormal_myelination | 0.54689969 |
| 111 | MP0003718_maternal_effect | 0.53413379 |
| 112 | MP0002132_abnormal_respiratory_system | 0.52926453 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.52639358 |
| 114 | MP0002249_abnormal_larynx_morphology | 0.52360559 |
| 115 | MP0002229_neurodegeneration | 0.51208984 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.50511742 |
| 117 | MP0005395_other_phenotype | 0.48723573 |
| 118 | MP0008874_decreased_physiological_sensi | 0.48448852 |
| 119 | MP0008872_abnormal_physiological_respon | 0.44628447 |
| 120 | MP0008873_increased_physiological_sensi | 0.44032189 |
| 121 | MP0003953_abnormal_hormone_level | 0.43136995 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.43098932 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.41693508 |
| 124 | MP0002928_abnormal_bile_duct | 0.40788361 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.39277650 |
| 126 | MP0009672_abnormal_birth_weight | 0.39146437 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.39062745 |
| 128 | MP0003075_altered_response_to | 0.38077126 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.37186677 |
| 130 | MP0000579_abnormal_nail_morphology | 0.35917582 |
| 131 | MP0005166_decreased_susceptibility_to | 0.34482649 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.34477656 |
| 133 | MP0004381_abnormal_hair_follicle | 0.33365676 |
| 134 | MP0003436_decreased_susceptibility_to | 0.31772879 |
| 135 | MP0002796_impaired_skin_barrier | 0.31003105 |
| 136 | MP0002970_abnormal_white_adipose | 0.29803408 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.29784273 |
| 138 | MP0001243_abnormal_dermal_layer | 0.28999052 |
| 139 | MP0003724_increased_susceptibility_to | 0.28914546 |
| 140 | MP0009115_abnormal_fat_cell | 0.28520543 |
| 141 | MP0002168_other_aberrant_phenotype | 0.27787445 |
| 142 | MP0004883_abnormal_blood_vessel | 0.27719795 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.26917214 |
| 144 | MP0000249_abnormal_blood_vessel | 0.26582300 |
| 145 | MP0001881_abnormal_mammary_gland | 0.25070545 |
| 146 | MP0006082_CNS_inflammation | 0.23656006 |
| 147 | MP0002090_abnormal_vision | 0.23511586 |
| 148 | MP0004264_abnormal_extraembryonic_tissu | 0.23017423 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.22681155 |
| 150 | MP0001853_heart_inflammation | 0.22348710 |
| 151 | MP0001944_abnormal_pancreas_morphology | 0.21988216 |
| 152 | MP0003959_abnormal_lean_body | 0.21849008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.62168414 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.41864388 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.33791859 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.84106311 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.55358771 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47772231 |
| 7 | Xanthomatosis (HP:0000991) | 6.21309371 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.59640147 |
| 9 | Complement deficiency (HP:0004431) | 5.32317538 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.78925841 |
| 11 | Joint hemorrhage (HP:0005261) | 4.73028204 |
| 12 | Hyperammonemia (HP:0001987) | 4.67956749 |
| 13 | Hyperglycinemia (HP:0002154) | 4.65972299 |
| 14 | Epidermoid cyst (HP:0200040) | 4.48456150 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.46793350 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44564033 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.42808541 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.36801042 |
| 19 | Ketosis (HP:0001946) | 4.29336990 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23856555 |
| 21 | Fat malabsorption (HP:0002630) | 4.23365326 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20903267 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.14057869 |
| 24 | Hyperglycinuria (HP:0003108) | 4.05479359 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.04907381 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.04907381 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.00558949 |
| 28 | Abnormality of complement system (HP:0005339) | 3.86716368 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83973126 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.74467152 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72264636 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.58191552 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32903956 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.32041023 |
| 35 | Myokymia (HP:0002411) | 3.28182669 |
| 36 | Steatorrhea (HP:0002570) | 3.26166026 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25392141 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.23849823 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.14575337 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10661561 |
| 41 | Neonatal hypoglycemia (HP:0001998) | 3.04883437 |
| 42 | Spontaneous abortion (HP:0005268) | 2.97668210 |
| 43 | Ketoacidosis (HP:0001993) | 2.97626771 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.95650589 |
| 45 | Myocardial infarction (HP:0001658) | 2.94119578 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.93171563 |
| 47 | Skin nodule (HP:0200036) | 2.79578573 |
| 48 | Metabolic acidosis (HP:0001942) | 2.76705669 |
| 49 | Nephritis (HP:0000123) | 2.73532465 |
| 50 | Fair hair (HP:0002286) | 2.71579697 |
| 51 | Lethargy (HP:0001254) | 2.69433579 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.65712867 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.61977273 |
| 54 | Gout (HP:0001997) | 2.58389415 |
| 55 | Vascular calcification (HP:0004934) | 2.57431294 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55287511 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.55287511 |
| 58 | Acanthocytosis (HP:0001927) | 2.54548742 |
| 59 | Spastic diplegia (HP:0001264) | 2.54319738 |
| 60 | Cerebral edema (HP:0002181) | 2.54274691 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.49076830 |
| 62 | Osteomalacia (HP:0002749) | 2.47270871 |
| 63 | Focal motor seizures (HP:0011153) | 2.42500745 |
| 64 | Cholelithiasis (HP:0001081) | 2.42483001 |
| 65 | Irritability (HP:0000737) | 2.41955372 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.41717461 |
| 67 | Mitral stenosis (HP:0001718) | 2.40471505 |
| 68 | Neonatal onset (HP:0003623) | 2.40253981 |
| 69 | Glomerulonephritis (HP:0000099) | 2.38162435 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.34319781 |
| 71 | Cholecystitis (HP:0001082) | 2.34319781 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.26732146 |
| 73 | Malnutrition (HP:0004395) | 2.22836179 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21902432 |
| 75 | Epileptic encephalopathy (HP:0200134) | 2.19228970 |
| 76 | Amyloidosis (HP:0011034) | 2.19053457 |
| 77 | Focal seizures (HP:0007359) | 2.18671036 |
| 78 | Brushfield spots (HP:0001088) | 2.17436059 |
| 79 | Esophageal varix (HP:0002040) | 2.16045129 |
| 80 | Pancreatitis (HP:0001733) | 2.15380091 |
| 81 | Hyperphosphaturia (HP:0003109) | 2.14080670 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.13270631 |
| 83 | Menorrhagia (HP:0000132) | 2.11253373 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.09288090 |
| 85 | Gingival bleeding (HP:0000225) | 2.08052670 |
| 86 | Opisthotonus (HP:0002179) | 2.07246447 |
| 87 | Vomiting (HP:0002013) | 2.07155513 |
| 88 | Late onset (HP:0003584) | 2.06610045 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.06357273 |
| 90 | Enlarged kidneys (HP:0000105) | 2.04065543 |
| 91 | Hypsarrhythmia (HP:0002521) | 2.02002264 |
| 92 | Thrombophlebitis (HP:0004418) | 2.01621237 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 2.01548466 |
| 94 | Febrile seizures (HP:0002373) | 2.00378341 |
| 95 | Poikilocytosis (HP:0004447) | 1.99827650 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97849302 |
| 97 | Generalized hypopigmentation of hair (HP:0011358) | 1.97286281 |
| 98 | Status epilepticus (HP:0002133) | 1.94757608 |
| 99 | Atonic seizures (HP:0010819) | 1.94429933 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.93607413 |
| 101 | Generalized aminoaciduria (HP:0002909) | 1.91304658 |
| 102 | Rickets (HP:0002748) | 1.89664927 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.88285273 |
| 104 | Hypophosphatemic rickets (HP:0004912) | 1.86155754 |
| 105 | Alkalosis (HP:0001948) | 1.85321111 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 1.85174605 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84156121 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.81697306 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.81697306 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.81591259 |
| 111 | Glycosuria (HP:0003076) | 1.81591259 |
| 112 | Torticollis (HP:0000473) | 1.79959751 |
| 113 | Bifid scrotum (HP:0000048) | 1.79787518 |
| 114 | Retinal atrophy (HP:0001105) | 1.78474719 |
| 115 | Renal cortical cysts (HP:0000803) | 1.77492242 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.77443753 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.77441054 |
| 118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77436997 |
| 119 | Hyperglycemia (HP:0003074) | 1.76267304 |
| 120 | Atrioventricular block (HP:0001678) | 1.75408638 |
| 121 | Pulmonary embolism (HP:0002204) | 1.75163550 |
| 122 | Abnormality of vitamin metabolism (HP:0100508) | 1.74991593 |
| 123 | Amblyopia (HP:0000646) | 1.74905177 |
| 124 | Acute hepatic failure (HP:0006554) | 1.74872807 |
| 125 | Generalized tonic-clonic seizures (HP:0002069) | 1.74690178 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.71701314 |
| 127 | Hypothermia (HP:0002045) | 1.65929218 |
| 128 | Blue irides (HP:0000635) | 1.64432812 |
| 129 | Arthropathy (HP:0003040) | 1.64411584 |
| 130 | Focal dystonia (HP:0004373) | 1.64188508 |
| 131 | Delayed myelination (HP:0012448) | 1.63125723 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.62216805 |
| 133 | Action tremor (HP:0002345) | 1.55558829 |
| 134 | Dyskinesia (HP:0100660) | 1.55303253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.73182128 |
| 2 | SIK1 | 4.57058031 |
| 3 | FGFR4 | 4.56522742 |
| 4 | NTRK3 | 4.33752361 |
| 5 | ERN1 | 4.20613638 |
| 6 | MAP3K9 | 3.72986067 |
| 7 | CASK | 3.09951123 |
| 8 | TAOK3 | 2.99968337 |
| 9 | INSRR | 2.98138141 |
| 10 | ERBB4 | 2.95374502 |
| 11 | MAP2K4 | 2.67606475 |
| 12 | MARK1 | 2.56044845 |
| 13 | PAK6 | 2.46096138 |
| 14 | PKN2 | 2.41045708 |
| 15 | MST1R | 1.96458815 |
| 16 | FLT3 | 1.96450884 |
| 17 | DAPK2 | 1.86176732 |
| 18 | MAPK11 | 1.85856415 |
| 19 | UHMK1 | 1.80699138 |
| 20 | ARAF | 1.79684339 |
| 21 | NTRK2 | 1.77521027 |
| 22 | TRIB3 | 1.76232544 |
| 23 | PLK2 | 1.69091786 |
| 24 | PIK3CG | 1.68097514 |
| 25 | MINK1 | 1.58972368 |
| 26 | LATS1 | 1.58912282 |
| 27 | TYK2 | 1.54342421 |
| 28 | ABL2 | 1.50730284 |
| 29 | PRKD3 | 1.47424162 |
| 30 | MAP4K2 | 1.45424023 |
| 31 | KSR2 | 1.43053489 |
| 32 | PTK6 | 1.41327535 |
| 33 | PAK3 | 1.37823864 |
| 34 | PINK1 | 1.36072556 |
| 35 | DAPK1 | 1.34168362 |
| 36 | FGFR2 | 1.33518717 |
| 37 | FRK | 1.32701371 |
| 38 | CDK5 | 1.30966549 |
| 39 | STK38 | 1.23869922 |
| 40 | NEK9 | 1.23031379 |
| 41 | MAP3K7 | 1.22145210 |
| 42 | JAK2 | 1.21208036 |
| 43 | PHKG1 | 1.18076514 |
| 44 | PHKG2 | 1.18076514 |
| 45 | KDR | 1.10702030 |
| 46 | CAMK2B | 1.07401391 |
| 47 | PRKAA2 | 1.03802870 |
| 48 | GRK6 | 1.03627377 |
| 49 | DYRK1A | 1.02779298 |
| 50 | GRK5 | 1.00606214 |
| 51 | STK38L | 1.00422168 |
| 52 | CAMK1 | 1.00037855 |
| 53 | PRKCZ | 0.98715087 |
| 54 | ERBB2 | 0.97968292 |
| 55 | CAMK1G | 0.97564833 |
| 56 | CAMKK2 | 0.96815749 |
| 57 | MAP2K3 | 0.95327350 |
| 58 | MAPK4 | 0.93548557 |
| 59 | MAPK13 | 0.92750866 |
| 60 | WNK3 | 0.92638526 |
| 61 | JAK1 | 0.90712174 |
| 62 | CDK15 | 0.88527503 |
| 63 | EPHA4 | 0.88325136 |
| 64 | TNK2 | 0.87084379 |
| 65 | MAP3K2 | 0.86802322 |
| 66 | CDK19 | 0.86015054 |
| 67 | TBK1 | 0.84974938 |
| 68 | MET | 0.84375010 |
| 69 | CDK18 | 0.82945127 |
| 70 | SGK1 | 0.82043273 |
| 71 | MAP3K10 | 0.81822439 |
| 72 | SIK2 | 0.81275116 |
| 73 | MAPK12 | 0.80972525 |
| 74 | CAMK2G | 0.80149346 |
| 75 | MAP3K14 | 0.79371282 |
| 76 | CDK6 | 0.78126290 |
| 77 | TSSK6 | 0.77829552 |
| 78 | CDK11A | 0.77328894 |
| 79 | PRKACG | 0.76261829 |
| 80 | STK11 | 0.74151687 |
| 81 | MAP2K6 | 0.74145237 |
| 82 | MAP3K11 | 0.73056192 |
| 83 | CDK14 | 0.72871839 |
| 84 | CAMK2A | 0.72666472 |
| 85 | MAPK15 | 0.71131924 |
| 86 | OXSR1 | 0.68457340 |
| 87 | NTRK1 | 0.67918295 |
| 88 | PRKAA1 | 0.67918043 |
| 89 | IRAK3 | 0.66575143 |
| 90 | PRKACA | 0.65167371 |
| 91 | MAP3K3 | 0.64826776 |
| 92 | SGK3 | 0.64477054 |
| 93 | GSK3A | 0.63997772 |
| 94 | RAF1 | 0.63789783 |
| 95 | PDPK1 | 0.62202215 |
| 96 | CSNK1E | 0.61518796 |
| 97 | CSNK1D | 0.61065745 |
| 98 | PRKCH | 0.59911435 |
| 99 | DYRK1B | 0.59867549 |
| 100 | NEK6 | 0.59389037 |
| 101 | MAPK7 | 0.58583496 |
| 102 | PRKCG | 0.57489732 |
| 103 | ALK | 0.56816189 |
| 104 | PRKG1 | 0.56730985 |
| 105 | CAMK1D | 0.56051191 |
| 106 | PRKCI | 0.55625496 |
| 107 | EPHB1 | 0.54645597 |
| 108 | TIE1 | 0.54540030 |
| 109 | AKT3 | 0.54514347 |
| 110 | BRAF | 0.54211442 |
| 111 | DYRK2 | 0.53965158 |
| 112 | CSK | 0.53604223 |
| 113 | MAP2K1 | 0.53027210 |
| 114 | ZAK | 0.52865668 |
| 115 | PTK2 | 0.52639319 |
| 116 | MAPK10 | 0.51286808 |
| 117 | CSNK1G1 | 0.50716319 |
| 118 | EPHA3 | 0.50383960 |
| 119 | PRKCE | 0.50366261 |
| 120 | CAMK2D | 0.49882353 |
| 121 | MAP3K5 | 0.48926573 |
| 122 | SGK2 | 0.48901631 |
| 123 | MAP2K7 | 0.48556157 |
| 124 | RET | 0.48211187 |
| 125 | PRPF4B | 0.47632160 |
| 126 | CDK4 | 0.47558775 |
| 127 | TAOK2 | 0.47363191 |
| 128 | RIPK1 | 0.46390255 |
| 129 | MAP3K4 | 0.46360374 |
| 130 | MAP3K13 | 0.46108298 |
| 131 | PRKCQ | 0.45409670 |
| 132 | PLK3 | 0.44881158 |
| 133 | LATS2 | 0.44429476 |
| 134 | CSNK1A1 | 0.43941943 |
| 135 | DAPK3 | 0.43307686 |
| 136 | PDK1 | 0.42265786 |
| 137 | PRKCB | 0.42240431 |
| 138 | FGFR3 | 0.41411735 |
| 139 | MAP2K2 | 0.40177530 |
| 140 | MAP3K6 | 0.39397867 |
| 141 | MTOR | 0.38883779 |
| 142 | CSNK1G2 | 0.38776182 |
| 143 | GRK1 | 0.38687771 |
| 144 | CSF1R | 0.38666492 |
| 145 | ICK | 0.38623126 |
| 146 | IGF1R | 0.38431221 |
| 147 | BRSK1 | 0.37944854 |
| 148 | SGK223 | 0.37765922 |
| 149 | SGK494 | 0.37765922 |
| 150 | CAMK4 | 0.34967257 |
| 151 | PKN1 | 0.33988341 |
| 152 | PDK3 | 0.33762421 |
| 153 | PDK4 | 0.33762421 |
| 154 | CSNK1G3 | 0.32958333 |
| 155 | IKBKE | 0.32749231 |
| 156 | IRAK2 | 0.32725414 |
| 157 | CAMKK1 | 0.32264682 |
| 158 | EGFR | 0.30250222 |
| 159 | PRKCA | 0.27685840 |
| 160 | TGFBR2 | 0.25596550 |
| 161 | MAP3K1 | 0.25044393 |
| 162 | CSNK1A1L | 0.24554670 |
| 163 | RPS6KA3 | 0.20988519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53341699 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70475021 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.57466123 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34337080 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99064851 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71535820 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68232520 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67651707 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.67453852 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61717954 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41224125 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37998656 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21659718 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11932137 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10469528 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.03678611 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92899347 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92733560 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90830746 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90357262 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89796670 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79712071 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79106951 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73143968 |
| 25 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71533469 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70722215 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68937262 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68420534 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68368881 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67849676 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62327693 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59796874 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59624262 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54342692 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52473075 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48801943 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45601741 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.44458175 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37174479 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33911568 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30929356 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28731549 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26090652 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25530426 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22917116 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22833113 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.15487479 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15288126 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10526767 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08715936 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06285625 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01738012 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01169404 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95334069 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93492411 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86420827 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85673657 |
| 58 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85187685 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84504549 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84007836 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.77621330 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71287007 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70575491 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63664686 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57657977 |
| 66 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56433030 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50273360 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49851939 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47212983 |
| 70 | * GABAergic synapse_Homo sapiens_hsa04727 | 0.40896497 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.40533489 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37973528 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.36716544 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.33991770 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33957478 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29204600 |
| 77 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27417155 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27244485 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24148916 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23748796 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21720053 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.20772955 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19828418 |
| 84 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19346015 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18643948 |
| 86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18142686 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.17295094 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16288494 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15411767 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.12323833 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.11398792 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10430243 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10115459 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10055748 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07447393 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.04019804 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03252251 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01724771 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2519281 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2457590 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2328340 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2280151 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2254266 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2217580 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2174066 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.2051906 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1921312 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1899734 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1848304 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1739506 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1696356 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1676981 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1656645 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0977110 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0877533 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0848249 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0558686 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0556675 |
| 119 | Salivary secretion_Homo sapiens_hsa04970 | -0.0437462 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0420876 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0415998 |
| 122 | Pertussis_Homo sapiens_hsa05133 | -0.0274913 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | -0.0253663 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | -0.0206498 |

